Affiliation:
1. Department of Surgery, Haukeland University Hospital, University of Bergen, Bergen, Norway
2. Section for Medical Informatics and Statistics, University of Bergen, Bergen, Norway
Abstract
Abstract
Between 1984 and 1987, 176 Norwegian patients with histologically verified unresectable pancreatic adenocarcinoma were randomized to double-blind treatment with oral tamoxifen (30 mg daily; 48 men and 44 women) or placebo (47 men and 37 women). Analysis of oestrogen receptor activity in the carcinomas was not performed. There were no statistically significant differences between the two groups according to age, Karnofsky performance index, tumour node metastasis (TNM) stage, operative treatment or other patient characteristics. The tamoxifen or placebo treatment continued to death or to 10 months after accrual into the trial was stopped. In the tamoxifen group, the mean and median survivals were 205 and 115 days, respectively. These values did not differ statistically from the 192 and 122 days, respectively, observed in the placebo group. Additional retrospective analyses of sex and stage revealed no beneficial effect of tamoxifen upon survival. For women in stage III (any TN1 M0), mean and median survivals were 255 and 191 days, respectively, compared with values of 84 and 45 days, respectively, in the placebo group (P = 0·011). After 2·5 years, three (7 per cent) women in the tamoxifen group were still alive compared with no survivors in the placebo group. No male patients survived beyond 2·5 years. This therapeutic result in a small subgroup of women is probably incidental and not an effect of tamoxifen.
Funder
Norwegian Cancer Society and ICI-Pharma
Publisher
Oxford University Press (OUP)
Reference35 articles.
1. Pancreatic cancer. Approach to diagnosis, selection for surgery and choice of operation;Moossa;Cancer,1982
2. Pancreatoduodenal resection and total pancrea-tectomy - an institutional review;Cooperman;Surgery,1981
3. Decreasing morbidity and mortality after pancreatoduo-denectomy;Grace;Am J Surg,1986
4. Factors influencing morbidity and mortality in pancreatoduodenectomy;Gilsdorf;Ann Surg,1973
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献